The FDA has approved Avance® (acellular nerve allograft-arwx) for the treatment of sensory nerve discontinuity.
Results that may be inaccessible to you are currently showing.
Hide inaccessible resultsResults that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback